| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2025 | TXMD Therapeuticsmd, Inc. | Walker Marlan D81 | Chief Executive Officer | Buy | 2,303 | $0.87 | $1,994.01 | +1.6% | +39.3% | +136.3% | |
| Apr 9, 2025 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 33,337 | $27.32 | $910,687.46 | -1.0% | +66.0% | -33.0% | |
| Apr 7, 2025 | UTHR United Therapeutics Corp | Dwek Raymond | Director | Sell | 4,000 | $284.55 | $1,138,200.00 | -69.6% | -0.5% | +93.9% | |
| Apr 4, 2025 | VREOF Vireo Growth Inc. | Chicago Atlantic Credit Opportunities, LLC | 10% Owner | Buy | 60,000 | $0.42 | $25,158.00 | +0.5% | - | - | |
| Apr 3, 2025 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 11,000 | $306.18 | $3,367,983.80 | -4.1% | -3.9% | +85.5% | |
| Apr 3, 2025 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 2,203 | $28.78 | $63,402.34 | -21.6% | +69.6% | -31.6% | |
| Apr 2, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 11,581 | $29.26 | $338,833.42 | -8.5% | +53.6% | -38.7% | |
| Apr 2, 2025 | TLPH Talphera, Inc. | Angotti Vincent J.56 | Chief Executive Officer | Buy | 213,310 | $0.59 | $124,999.66 | +112.0% | -22.6% | +33.4% | |
| Apr 1, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $28.38 | $14,190.25 | -0.7% | -18.8% | -28.5% | |
| Apr 1, 2025 | RMTI Rockwell Medical, Inc. | Neri Jesse61 | SVP, Finance And CFO | Sell | 886 | $1.10 | $974.60 | -2.9% | -21.5% | -13.9% | |
| Apr 1, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Patel Gautam | Director | Sell | 80,000 | $8.30 | $664,000.00 | -4.4% | -1.7% | +54.4% | |
| Apr 1, 2025 | RMTI Rockwell Medical, Inc. | Strobeck Mark72 | President And CEO | Sell | 6,926 | $1.08 | $7,480.08 | -5.3% | -21.5% | -13.9% | |
| Apr 1, 2025 | RMTI Rockwell Medical, Inc. | Chole Timothy73 | SVP, Chief Commercial Officer | Sell | 2,868 | $1.08 | $3,097.44 | -5.9% | -21.5% | -13.9% | |
| Mar 31, 2025 | CGC Canopy Growth Corp | Yanofsky Theresa75 | Director | Sell | 2,004 | $0.92 | $1,843.68 | -9.0% | +34.1% | +4.3% | |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Frates James M83 | Chief Financial Officer | Sell | 10,896 | $3.47 | $37,805.85 | -3.6% | +81.1% | +292.7% | |
| Mar 31, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 3,236 | $27.77 | $89,863.72 | -1.9% | +68.7% | -29.7% | |
| Mar 31, 2025 | CGC Canopy Growth Corp | Kruh Willy74 | Director | Sell | 2,012 | $0.92 | $1,851.04 | -17.8% | +34.1% | +4.3% | |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Cohen Joshua B60 | Co-chief Executive Officer | Sell | 21,490 | $3.47 | $74,482.19 | -0.6% | +81.1% | +292.7% | |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Klee Justin B.60 | Co-chief Executive Officer | Sell | 21,490 | $3.46 | $74,454.25 | -0.6% | +81.1% | +292.7% | |
| Mar 31, 2025 | CGC Canopy Growth Corp | Lazzarato David Angelo75 | Director | Sell | 3,004 | $0.92 | $2,763.68 | -11.6% | +34.1% | +4.3% | |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L64 | Chief Medical Officer | Sell | 12,425 | $3.47 | $43,082.45 | -6.0% | +81.1% | +292.7% | |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina53 | Chief Legal Officer | Sell | 9,192 | $3.48 | $31,954.15 | -4.7% | +81.1% | +292.7% | |
| Mar 31, 2025 | VREOF Vireo Growth Inc. | Chicago Atlantic Credit Opportunities, LLC | 10% Owner | Buy | 87,500 | $0.43 | $37,520.63 | +10.7% | - | - | |
| Mar 31, 2025 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 168 | $5.24 | $880.90 | - | -20.8% | -23.2% | |
| Mar 31, 2025 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 875 | $5.20 | $4,548.15 | - | -20.8% | -23.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.